Shivanjali Shankaran, MD - Medicare Infectious Disease in Chicago, IL

Shivanjali Shankaran, MD is a medicare enrolled "Internal Medicine - Infectious Disease" physician in Chicago, Illinois. She graduated from medical school in 2002 and has 22 years of diverse experience with area of expertise as Infectious Disease. She is a member of the group practice Cook County, Rush University Medical Center and her current practice location is 600 S Paulina St Ste 140, Chicago, Illinois. You can reach out to her office (for appointments etc.) via phone at (312) 942-5865.

Shivanjali Shankaran is licensed to practice in Illinois (license number 036-143813) and she also participates in the medicare program. She accepts medicare assignments (which means she accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and her NPI Number is 1861628364.

Contact Information

Shivanjali Shankaran, MD
600 S Paulina St Ste 140,
Chicago, IL 60612-3806
(312) 942-5865
Not Available



Physician's Profile

Full NameShivanjali Shankaran
GenderFemale
SpecialityInfectious Disease
Experience22 Years
Location600 S Paulina St Ste 140, Chicago, Illinois
Accepts Medicare AssignmentsYes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Shivanjali Shankaran graduated from medical school in 2002
  NPI Data:
  • NPI Number: 1861628364
  • Provider Enumeration Date: 06/10/2009
  • Last Update Date: 07/18/2023
  Medicare PECOS Information:
  • PECOS PAC ID: 2668636465
  • Enrollment ID: I20171109000511

Medical Identifiers

Medical identifiers for Shivanjali Shankaran such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1861628364NPI-NPPES
-032OtherVATRICARE/CHAMPUS
1861628364OtherVAUNITED HEALTHCARE
PAROtherVAMULTIPLAN
456782OtherVAANTHEM BC/BS
5920094MedicaidNC
PAROtherVAUSA MANAGED CARE
PAROtherVAVIRGINIA HEALTH NETWORK
PAROtherVACORVEL
10091628OtherVAOPTIMA HEALTH
1861628364OtherVAVIRGINIA PREMIER HEALTH PLAN
1861628364MedicaidVA
PAROtherVACIGNA
1861628364OtherVAFIRST HEALTH COMMERICAL/COVENTRY HEALTH
PAROtherVAAETNA

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
207RI0200XInternal Medicine - Infectious Disease 0101249722 (Virginia)Secondary
207R00000XInternal Medicine 036-143813 (Illinois)Secondary
207RI0200XInternal Medicine - Infectious Disease 036-143813 (Illinois)Primary

Medical Facilities Affiliation

Facility NameLocationFacility Type
Rush University Medical CenterChicago, ILHospital

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
Cook County2860398088619
Rush University Medical Center54966588741007

News Archive

Amgen and Roche end EPO patent infringement dispute

Amgen announced today that the United States (U.S.) District Court in Boston has entered final judgment and a permanent injunction against Roche prohibiting Roche from infringing Amgen's patents on recombinant erythropoietin (EPO), thus bringing the five-year patent infringement dispute to an end.

MRI and ultrasound can detect fetal brain damage caused by Zika in utero

Clinicians managing Zika-affected pregnancies should use magnetic resonance imaging (MRI) in addition to standard ultrasound (US) because the more detailed MRI images can reveal more extensive areas of damage to the developing fetal brain, according to research presented during IDWeek 2017.

Book about triple negative breast cancer

Hope, Treatment, and Recovery by Patricia Prijatel is exactly that-an encouraging guide to surviving a disease often referred to as, "a particularly aggressive and difficult to treat form of cancer." Prijatel is a health journalist who, at the age of 60 was diagnosed with triple negative breast cancer [TNBC] a disease which disproportionately affects young women and women of African descent. No book existed on TNBC at the time of Prijatel's diagnosis.

Researchers see plectasin as promising lead compound for new antibiotics

An active compound from fungi and lower animals may well be suitable as an effective weapon against dangerous bacteria. We're talking about plectasin, a small protein molecule that can even destroy highly resistant bacteria . Researchers at the Universities of Bonn, Utrecht, Aalborg and of the Danish company Novozymes AS have shed light on how the substance does this.

GNA Biosolutions launches world's first Laser PCR platform at Medica Trade Fair

GNA Biosolutions GmbH, a molecular technology company based in Martinsried, Germany, today announced the launch of Pharos V8, the world's first Laser PCR platform. Pharos V8, an ultrafast PCR instrument for in vitro research use, will be showcased at the Medica Trade Fair (Exhibition Hall 3, Booth E93) from November 13-16.

Read more Medical News

› Verified 6 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Shivanjali Shankaran allows following entities to bill medicare on her behalf.
Entity NameCook County
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1588612832
PECOS PAC ID: 2860398088
Enrollment ID: O20031209000747

News Archive

Amgen and Roche end EPO patent infringement dispute

Amgen announced today that the United States (U.S.) District Court in Boston has entered final judgment and a permanent injunction against Roche prohibiting Roche from infringing Amgen's patents on recombinant erythropoietin (EPO), thus bringing the five-year patent infringement dispute to an end.

MRI and ultrasound can detect fetal brain damage caused by Zika in utero

Clinicians managing Zika-affected pregnancies should use magnetic resonance imaging (MRI) in addition to standard ultrasound (US) because the more detailed MRI images can reveal more extensive areas of damage to the developing fetal brain, according to research presented during IDWeek 2017.

Book about triple negative breast cancer

Hope, Treatment, and Recovery by Patricia Prijatel is exactly that-an encouraging guide to surviving a disease often referred to as, "a particularly aggressive and difficult to treat form of cancer." Prijatel is a health journalist who, at the age of 60 was diagnosed with triple negative breast cancer [TNBC] a disease which disproportionately affects young women and women of African descent. No book existed on TNBC at the time of Prijatel's diagnosis.

Researchers see plectasin as promising lead compound for new antibiotics

An active compound from fungi and lower animals may well be suitable as an effective weapon against dangerous bacteria. We're talking about plectasin, a small protein molecule that can even destroy highly resistant bacteria . Researchers at the Universities of Bonn, Utrecht, Aalborg and of the Danish company Novozymes AS have shed light on how the substance does this.

GNA Biosolutions launches world's first Laser PCR platform at Medica Trade Fair

GNA Biosolutions GmbH, a molecular technology company based in Martinsried, Germany, today announced the launch of Pharos V8, the world's first Laser PCR platform. Pharos V8, an ultrafast PCR instrument for in vitro research use, will be showcased at the Medica Trade Fair (Exhibition Hall 3, Booth E93) from November 13-16.

Read more Medical News

› Verified 6 days ago

Entity NameRush University Medical Center
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1093819542
PECOS PAC ID: 5496658874
Enrollment ID: O20040202000228

News Archive

Amgen and Roche end EPO patent infringement dispute

Amgen announced today that the United States (U.S.) District Court in Boston has entered final judgment and a permanent injunction against Roche prohibiting Roche from infringing Amgen's patents on recombinant erythropoietin (EPO), thus bringing the five-year patent infringement dispute to an end.

MRI and ultrasound can detect fetal brain damage caused by Zika in utero

Clinicians managing Zika-affected pregnancies should use magnetic resonance imaging (MRI) in addition to standard ultrasound (US) because the more detailed MRI images can reveal more extensive areas of damage to the developing fetal brain, according to research presented during IDWeek 2017.

Book about triple negative breast cancer

Hope, Treatment, and Recovery by Patricia Prijatel is exactly that-an encouraging guide to surviving a disease often referred to as, "a particularly aggressive and difficult to treat form of cancer." Prijatel is a health journalist who, at the age of 60 was diagnosed with triple negative breast cancer [TNBC] a disease which disproportionately affects young women and women of African descent. No book existed on TNBC at the time of Prijatel's diagnosis.

Researchers see plectasin as promising lead compound for new antibiotics

An active compound from fungi and lower animals may well be suitable as an effective weapon against dangerous bacteria. We're talking about plectasin, a small protein molecule that can even destroy highly resistant bacteria . Researchers at the Universities of Bonn, Utrecht, Aalborg and of the Danish company Novozymes AS have shed light on how the substance does this.

GNA Biosolutions launches world's first Laser PCR platform at Medica Trade Fair

GNA Biosolutions GmbH, a molecular technology company based in Martinsried, Germany, today announced the launch of Pharos V8, the world's first Laser PCR platform. Pharos V8, an ultrafast PCR instrument for in vitro research use, will be showcased at the Medica Trade Fair (Exhibition Hall 3, Booth E93) from November 13-16.

Read more Medical News

› Verified 6 days ago

Entity NameRush University Medical Center
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1518196138
PECOS PAC ID: 8628114956
Enrollment ID: O20090930000174

News Archive

Amgen and Roche end EPO patent infringement dispute

Amgen announced today that the United States (U.S.) District Court in Boston has entered final judgment and a permanent injunction against Roche prohibiting Roche from infringing Amgen's patents on recombinant erythropoietin (EPO), thus bringing the five-year patent infringement dispute to an end.

MRI and ultrasound can detect fetal brain damage caused by Zika in utero

Clinicians managing Zika-affected pregnancies should use magnetic resonance imaging (MRI) in addition to standard ultrasound (US) because the more detailed MRI images can reveal more extensive areas of damage to the developing fetal brain, according to research presented during IDWeek 2017.

Book about triple negative breast cancer

Hope, Treatment, and Recovery by Patricia Prijatel is exactly that-an encouraging guide to surviving a disease often referred to as, "a particularly aggressive and difficult to treat form of cancer." Prijatel is a health journalist who, at the age of 60 was diagnosed with triple negative breast cancer [TNBC] a disease which disproportionately affects young women and women of African descent. No book existed on TNBC at the time of Prijatel's diagnosis.

Researchers see plectasin as promising lead compound for new antibiotics

An active compound from fungi and lower animals may well be suitable as an effective weapon against dangerous bacteria. We're talking about plectasin, a small protein molecule that can even destroy highly resistant bacteria . Researchers at the Universities of Bonn, Utrecht, Aalborg and of the Danish company Novozymes AS have shed light on how the substance does this.

GNA Biosolutions launches world's first Laser PCR platform at Medica Trade Fair

GNA Biosolutions GmbH, a molecular technology company based in Martinsried, Germany, today announced the launch of Pharos V8, the world's first Laser PCR platform. Pharos V8, an ultrafast PCR instrument for in vitro research use, will be showcased at the Medica Trade Fair (Exhibition Hall 3, Booth E93) from November 13-16.

Read more Medical News

› Verified 6 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Shivanjali Shankaran is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Shivanjali Shankaran, MD
600 S Paulina St Ste 140,
Chicago, IL 60612-3806

Ph: (312) 942-5865
Shivanjali Shankaran, MD
600 S Paulina St Ste 140,
Chicago, IL 60612-3806

Ph: (312) 942-5865

News Archive

Amgen and Roche end EPO patent infringement dispute

Amgen announced today that the United States (U.S.) District Court in Boston has entered final judgment and a permanent injunction against Roche prohibiting Roche from infringing Amgen's patents on recombinant erythropoietin (EPO), thus bringing the five-year patent infringement dispute to an end.

MRI and ultrasound can detect fetal brain damage caused by Zika in utero

Clinicians managing Zika-affected pregnancies should use magnetic resonance imaging (MRI) in addition to standard ultrasound (US) because the more detailed MRI images can reveal more extensive areas of damage to the developing fetal brain, according to research presented during IDWeek 2017.

Book about triple negative breast cancer

Hope, Treatment, and Recovery by Patricia Prijatel is exactly that-an encouraging guide to surviving a disease often referred to as, "a particularly aggressive and difficult to treat form of cancer." Prijatel is a health journalist who, at the age of 60 was diagnosed with triple negative breast cancer [TNBC] a disease which disproportionately affects young women and women of African descent. No book existed on TNBC at the time of Prijatel's diagnosis.

Researchers see plectasin as promising lead compound for new antibiotics

An active compound from fungi and lower animals may well be suitable as an effective weapon against dangerous bacteria. We're talking about plectasin, a small protein molecule that can even destroy highly resistant bacteria . Researchers at the Universities of Bonn, Utrecht, Aalborg and of the Danish company Novozymes AS have shed light on how the substance does this.

GNA Biosolutions launches world's first Laser PCR platform at Medica Trade Fair

GNA Biosolutions GmbH, a molecular technology company based in Martinsried, Germany, today announced the launch of Pharos V8, the world's first Laser PCR platform. Pharos V8, an ultrafast PCR instrument for in vitro research use, will be showcased at the Medica Trade Fair (Exhibition Hall 3, Booth E93) from November 13-16.

Read more News

› Verified 6 days ago


Internal Medicine Doctors in Chicago, IL

Dr. Sorin C Danciu, M.D.
Infectious Disease
Medicare: Accepting Medicare Assignments
Practice Location: 3134 N Clark St, Chicago, IL 60657
Phone: 773-880-9722    
Anoopa A. Koshy, MD
Infectious Disease
Medicare: Accepting Medicare Assignments
Practice Location: 259 E Erie St Ste 2200, Chicago, IL 60611
Phone: 312-926-6000    
William Edmond Gerardi, M.D.
Infectious Disease
Medicare: Not Enrolled in Medicare
Practice Location: 3730 N Lake Shore Dr, Apartment 2a, Chicago, IL 60613
Phone: 773-244-3060    
Suparna Dutta, M.D.
Infectious Disease
Medicare: Accepting Medicare Assignments
Practice Location: 1700 W Van Buren St, Suite 500, Chicago, IL 60612
Phone: 312-942-4200    Fax: 312-942-3568
Alexandra Dumitrescu,
Infectious Disease
Medicare: Accepting Medicare Assignments
Practice Location: 5841 S Maryland Ave, Chicago, IL 60637
Phone: 888-824-0200    
Dr. Mitesh Mahesh Kabadi, M.D.
Infectious Disease
Medicare: Accepting Medicare Assignments
Practice Location: 1725 W Harrison St Ste 1159, Chicago, IL 60612
Phone: 312-942-5020    
Dr. Marta Batus, MD
Infectious Disease
Medicare: Accepting Medicare Assignments
Practice Location: 1725 W Harrison St, Suite 809, Chicago, IL 60612
Phone: 312-563-2487    Fax: 312-942-3192

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.